Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for CASI Pharmaceuticals, Inc. (CASI)

« Back to company index

CASI Chatter Timeline

Stock Ticker for CASI

Most Active Tweeters for CASI

UserTweets
@Gambiste1 3
@EnterpriseLeade 1
@ResearchPool 1
@otcdynamics 1
@TranscriptDaily 1

Recent Tweets for CASI

1stOncology @1stOncology
#CASIPharmaceuticals Announces China #NMPA Approval Of #CNCT19 (#CD19 #CART) Clinical Trial Applications $CASI https://t.co/HXa3pCF5EV
December 4th 2019, 7:12am
Gambiste1 @Gambiste1
RT @otcdynamics: $CASI CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications https://t.co/m…
December 3rd 2019, 10:12pm
Gambiste1 @Gambiste1
RT @newsfilterio: CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications $CASI https://t.co/…
December 3rd 2019, 10:12pm
otcdynamics @otcdynamics
$CASI CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications https://t.co/mbQTGu9IsH
December 3rd 2019, 9:12pm
newsfilterio @newsfilterio
CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications $CASI https://t.co/YlCcd3sCIN
December 3rd 2019, 9:12pm
dakotafinancial @dakotafinancial
Amgen $AMGN and CASI Pharmaceuticals $CASI Head to Head Contrast https://t.co/mg1WFZqRMX
December 3rd 2019, 1:12am
intercooleronli @intercooleronli
CASI Pharmaceuticals $CASI Stock Passes Above Two Hundred Day Moving Average of $3.21 https://t.co/oa2c5fLtXt #investingnews
November 30th 2019, 7:11am
ledgerzette @ledgerzette
CASI Pharmaceuticals $CASI Stock Passes Above Two Hundred Day Moving Average of $3.21 https://t.co/tPvPdCuzO6 #stocks
November 30th 2019, 7:11am
AmericanBanking @AmericanBanking
CASI Pharmaceuticals $CASI and Amgen $AMGN Head to Head Comparison https://t.co/j2XlBUBLtc #stocks
November 30th 2019, 2:11am
TranscriptDaily @TranscriptDaily
CASI Pharmaceuticals $CASI and Amgen $AMGN Head to Head Comparison https://t.co/mfuMZNC8Y5
November 30th 2019, 2:11am
EnterpriseLeade @EnterpriseLeade
Analyzing CASI Pharmaceuticals $CASI and Amgen $AMGN https://t.co/3IzLYxnURi
November 30th 2019, 2:11am
ConsumerFeed @ConsumerFeed
CASI Pharmaceuticals $CASI Stock Price Crosses Above 200-Day Moving Average of $3.21 https://t.co/Es2bgBkNln
November 28th 2019, 5:11pm
fintel_io @fintel_io
$CASI / CASI Pharmaceuticals files form 8-K - Entry into a Material Definitive Agreement https://t.co/4xBuu3moGu
November 26th 2019, 4:11pm
investor_feed @investor_feed
$CASI 8-K CASI Pharmaceuticals (26 Nov, 4:01pm) ? Entry into a Material Definitive Agreement… https://t.co/UmPcWmV4Te
November 26th 2019, 4:11pm
CostanzTrade @CostanzTrade
$CASI pattern on watch
November 26th 2019, 10:11am
TrdngDrivatives @TrdngDrivatives
RT @ResearchPool: $CASI #CASI Pharmaceuticals CASI: Strong start for product sales: | https://t.co/1RDW4pty0O #equity #stocks https://t.co/…
November 25th 2019, 8:11pm
ResearchPool @ResearchPool
$CASI #CASI Pharmaceuticals CASI: Strong start for product sales: | https://t.co/1RDW4pty0O #equity #stocks https://t.co/84G2wZxHKz
November 25th 2019, 8:11pm
Gambiste1 @Gambiste1
RT @gcassidy718: $CASI watching closely ... Over $3.74 this rips 3.34 % change recently https://t.co/W6REGbUBhi
November 25th 2019, 4:11am
gcassidy718 @gcassidy718
$CASI watching closely ... Over $3.74 this rips 3.34 % change recently https://t.co/W6REGbUBhi
November 25th 2019, 2:11am
gcassidy718 @gcassidy718
$CASI this is capitalism 3.34 % change recently https://t.co/W6REGbUBhi
November 23rd 2019, 5:11pm
dispatchtribune @dispatchtribune
CASI Pharmaceuticals $CASI Rating Increased to Sell at BidaskClub https://t.co/U2sUW3CrIZ
November 23rd 2019, 7:11am
OlympiaReport @OlympiaReport
CASI Pharmaceuticals $CASI Rating Increased to Sell at BidaskClub https://t.co/Bh2URmonJB
November 23rd 2019, 7:11am
ZolmaxNews @ZolmaxNews
CASI Pharmaceuticals $CASI Shares Pass Above Two Hundred Day Moving Average of $3.21 https://t.co/8FpzRKJAuh
November 22nd 2019, 6:11am
dakotafinancial @dakotafinancial
CASI Pharmaceuticals $CASI Raised to Sell at BidaskClub https://t.co/3oaTdwsoea
November 22nd 2019, 12:11am
TheMarketsDaily @TheMarketsDaily
CASI Pharmaceuticals $CASI Raised to Sell at BidaskClub https://t.co/MjTMITg2UV
November 22nd 2019, 12:11am
BlueBioNow @BlueBioNow
$CASI What happened??? why the bounce?? 4.23 % change recently https://t.co/LTzgM8iLYu
November 20th 2019, 4:11pm
dakotafinancial @dakotafinancial
CASI Pharmaceuticals $CASI Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS https://t.co/mrNlL7S7Mi
November 15th 2019, 2:11pm
ConsumerFeed @ConsumerFeed
CASI Pharmaceuticals $CASI Announces Quarterly Earnings Results https://t.co/UIPtVJEuN8
November 14th 2019, 3:11pm
ledgerzette @ledgerzette
CASI Pharmaceuticals $CASI Posts Earnings Results, Beats Expectations By $0.01 EPS https://t.co/aEO6oYTqvU #stocks
November 13th 2019, 9:11pm
ledgerzette @ledgerzette
CASI Pharmaceuticals $CASI Posts Earnings Results, Beats Expectations By $0.01 EPS https://t.co/gXpiOxvcv3 #stocks
November 13th 2019, 8:11pm
stocknewstimes @stocknewstimes
CASI Pharmaceuticals $CASI Announces Earnings Results, Beats Expectations By $0.01 EPS https://t.co/nYOOVRgGkT
November 13th 2019, 8:11pm
TheMarketsDaily @TheMarketsDaily
CASI Pharmaceuticals $CASI Posts Earnings Results, Beats Expectations By $0.01 EPS https://t.co/JndagYIttd
November 13th 2019, 7:11pm
intercooleronli @intercooleronli
CASI Pharmaceuticals $CASI Posts Earnings Results, Beats Expectations By $0.01 EPS https://t.co/drAkGJTVE9 #investingnews
November 13th 2019, 7:11pm
AmericanBanking @AmericanBanking
CASI Pharmaceuticals $CASI Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS https://t.co/k0nZfEOnqe #stocks
November 13th 2019, 7:11pm
fintel_io @fintel_io
$CASI / CASI Pharmaceuticals files form 8-K - Departure of Directors or Certain Officers; Election of Directors; Ap… https://t.co/v0vEL6R8ic
November 13th 2019, 4:11pm
fintel_io @fintel_io
$CASI / CASI Pharmaceuticals files form 8-K - Financial Statements and Exhibits, Results of Operations and Financia… https://t.co/g9aHbb3UkK
November 12th 2019, 2:11pm
marketexclusive @marketexclusive
$CASI CASI PHARMACEUTICALS, INC. (NASDAQ:CASI) Files An 8-K Results of Operations and Financial Condition https://t.co/X67eTh37ye
November 12th 2019, 1:11pm
StockNewsNow @StockNewsNow
$CASI CASI Pharmaceuticals Announces Third Quarter 2019 Financial Results https://t.co/H4MkjOuuY1
November 12th 2019, 11:11am
SwingTradeBot @SwingTradeBot
200 DMA Support today: $USLV $CASI ... https://t.co/LjP7KUcNnp
November 12th 2019, 11:11am
newsfilterio @newsfilterio
CASI Pharmaceuticals EPS beats by $0.01 $CASI https://t.co/oRHpARkNIc
November 12th 2019, 7:11am
MarketCurrents @MarketCurrents
$CASI - CASI Pharmaceuticals EPS beats by $0.01 https://t.co/vSSxQl4P3J
November 12th 2019, 7:11am
StockNewsWires @StockNewsWires
$CASI: CASI Pharmaceuticals Announces Third Quarter 2019 Financial …: https://t.co/xjYl4bAanK
November 12th 2019, 7:11am
TheMarketsDaily @TheMarketsDaily
CASI Pharmaceuticals $CASI Cut to “Strong Sell” at BidaskClub https://t.co/6qjC2peAtm
November 10th 2019, 3:11pm
EnterpriseLeade @EnterpriseLeade
CASI Pharmaceuticals $CASI Downgraded by BidaskClub https://t.co/GDh31c9oZZ
November 9th 2019, 12:11pm
dispatchtribune @dispatchtribune
CASI Pharmaceuticals $CASI Downgraded to “Strong Sell” at BidaskClub https://t.co/Zm0n9pn7be
November 9th 2019, 12:11pm
dailypoliticaln @dailypoliticaln
CASI Pharmaceuticals $CASI Downgraded to “Strong Sell” at BidaskClub https://t.co/ee5jmlwMET
November 7th 2019, 10:11pm
ZolmaxNews @ZolmaxNews
CASI Pharmaceuticals $CASI Downgraded to “Strong Sell” at BidaskClub https://t.co/Hu6LovBhuJ
November 7th 2019, 10:11pm
ThisLincolnian @ThisLincolnian
CASI Pharmaceuticals $CASI Stock Price Crosses Above 200 Day Moving Average of $3.21 https://t.co/aG5pYnFAJ3
November 7th 2019, 10:11am
WeekHerald @WeekHerald
CASI Pharmaceuticals $CASI Shares Pass Above 200 Day Moving Average of $3.21 https://t.co/uVskhbIgLs
November 7th 2019, 10:11am
otcdynamics @otcdynamics
$CASI CASI Pharmaceuticals Enters Exclusive China Distribution License Agreement For Octreotide Long Acting https://t.co/5JmBO8krch
November 7th 2019, 7:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.